Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06555497

Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis

A Pilot Study of Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Mild-moderate Plaque-type Psoriasis

Sponsor: Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium

Conditions Pilot Study Psoriasis

Interventions clobetasol propionate 0.05% ointment topical 1% methotrexate gel

Updated 3 times since 2024 Last updated: Aug 14, 2024 Started: Jan 1, 2022 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06555497, this EARLY_PHASE1 trial focuses on Pilot Study and Psoriasis and remains completed. Sponsored by Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Completed EARLY_PHASE1
Sep 2025 — Feb 2026 [monthly]

Completed EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed EARLY_PHASE1

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium

Data source: Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caloocan, Philippines